Detalhe da pesquisa
1.
Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis.
N Engl J Med
; 376(8): 717-728, 2017 02 23.
Artigo
Inglês
| MEDLINE | ID: mdl-28225674
2.
Population pharmacokinetics of fusidic acid: rationale for front-loaded dosing regimens due to autoinhibition of clearance.
Antimicrob Agents Chemother
; 57(1): 498-507, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23147726
3.
Comparison of plasma, epithelial lining fluid, and alveolar macrophage concentrations of solithromycin (CEM-101) in healthy adult subjects.
Antimicrob Agents Chemother
; 56(10): 5076-81, 2012 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-22802254
4.
Pharmacokinetics and safety of single, multiple, and loading doses of fusidic acid in healthy subjects.
Clin Infect Dis
; 52 Suppl 7: S504-12, 2011 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-21546627
5.
A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections.
Clin Infect Dis
; 52 Suppl 7: S520-6, 2011 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-21546629
6.
Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects.
Antimicrob Agents Chemother
; 55(5): 1997-2003, 2011 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21282444
7.
Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.
Diabetes Care
; 26(2): 421-6, 2003 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-12547873
8.
Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a phase I/II clinical trial.
Metabolism
; 53(1): 54-8, 2004 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-14681842
9.
Pharmacokinetics of modified oral calcitonin product in healthy volunteers.
Pharmacotherapy
; 24(8): 994-1001, 2004 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-15338848
10.
Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2.
Diabetes Technol Ther
; 4(4): 459-66, 2002.
Artigo
Inglês
| MEDLINE | ID: mdl-12396740
11.
Simulated first-phase insulin release using Humulin or insulin analog HIM2 is associated with prolonged improvement in postprandial glycemia.
Am J Physiol Endocrinol Metab
; 289(1): E46-52, 2005 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-15713685